|
MRPL44 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.02771174587724E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.04780000032801E-07 |
| Normal-vs-Stage2 |
5.75669999999251E-05 |
| Normal-vs-Stage3 |
1.15685239165941E-13 |
| Normal-vs-Stage4 |
1.29229960066368E-10 |
| Stage1-vs-Stage2 |
1.275570E-01 |
| Stage1-vs-Stage3 |
7.79390000000824E-05 |
| Stage1-vs-Stage4 |
7.404800E-04 |
| Stage2-vs-Stage3 |
1.988990E-01 |
| Stage2-vs-Stage4 |
2.556200E-01 |
| Stage3-vs-Stage4 |
9.381200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66489044772788E-12 |
| Normal-vs-AfricanAmerican |
7.648400E-04 |
| Normal-vs-Asian |
5.838800E-01 |
| Caucasian-vs-AfricanAmerican |
7.484000E-01 |
| Caucasian-vs-Asian |
5.867600E-01 |
| AfricanAmerican-vs-Asian |
5.591200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
6.175100E-04 |
| Male-vs-Female |
3.84429999999991E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.944100E-03 |
| Normal-vs-Age(41-60Yrs) |
4.23560075901719E-11 |
| Normal-vs-Age(61-80Yrs) |
1.7824997033955E-10 |
| Normal-vs-Age(81-100Yrs) |
1.303030E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.589000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.068600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.350000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.614200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.338800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.740000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.622170E-01 |
| Normal-vs-Grade 2 |
1.63439999978365E-07 |
| Normal-vs-Grade 3 |
1.02719999173218E-09 |
| Normal-vs-Grade 4 |
<1E-12 |
| Grade 1-vs-Grade 2 |
5.736200E-01 |
| Grade 1-vs-Grade 3 |
3.421200E-01 |
| Grade 1-vs-Grade 4 |
1.101700E-03 |
| Grade 2-vs-Grade 3 |
2.489000E-01 |
| Grade 2-vs-Grade 4 |
1.59269999966405E-07 |
| Grade 3-vs-Grade 4 |
3.58959999999797E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.224300E-02 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
1.13242748511766E-14 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.72630054485046E-10 |
| Normal-vs-N1 |
1.421940E-02 |
| N0-vs-N1 |
2.601800E-01 |
|
|
